SVB Leerink raised the price target for the Pfizer Inc. (NYSE:PFE) stock to ‘a Mkt perform’. The rating was released on May 23, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Neutral to Buy, with a price target set at $70. The stock was reiterated by Bernstein, who disclosed in a research note on January 03, 2023, to Mkt Perform and set the price objective to $65. In their research brief published December 20, 2021, Cowen analysts reiterated the Pfizer Inc.